ATE416629T1 - Antioxidative zusammensetzungen - Google Patents

Antioxidative zusammensetzungen

Info

Publication number
ATE416629T1
ATE416629T1 AT03774827T AT03774827T ATE416629T1 AT E416629 T1 ATE416629 T1 AT E416629T1 AT 03774827 T AT03774827 T AT 03774827T AT 03774827 T AT03774827 T AT 03774827T AT E416629 T1 ATE416629 T1 AT E416629T1
Authority
AT
Austria
Prior art keywords
vitamin
antioxidant compositions
epicatechin
epigallocatechin
gallate
Prior art date
Application number
AT03774827T
Other languages
English (en)
Inventor
Thomas Lines
Mitsunori Ono
Original Assignee
Quercegen Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/302,544 external-priority patent/US6821536B2/en
Application filed by Quercegen Holdings Llc filed Critical Quercegen Holdings Llc
Application granted granted Critical
Publication of ATE416629T1 publication Critical patent/ATE416629T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Insulating Materials (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Paper (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AT03774827T 2002-10-23 2003-10-14 Antioxidative zusammensetzungen ATE416629T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42098602P 2002-10-23 2002-10-23
US10/302,544 US6821536B2 (en) 2002-11-22 2002-11-22 Antioxidative compositions

Publications (1)

Publication Number Publication Date
ATE416629T1 true ATE416629T1 (de) 2008-12-15

Family

ID=32658824

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03774827T ATE416629T1 (de) 2002-10-23 2003-10-14 Antioxidative zusammensetzungen
AT03779239T ATE500747T1 (de) 2002-10-23 2003-10-23 Zusammensetzung zur erhöhung der leistungsfähigkeit des körpers

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03779239T ATE500747T1 (de) 2002-10-23 2003-10-23 Zusammensetzung zur erhöhung der leistungsfähigkeit des körpers

Country Status (12)

Country Link
EP (2) EP1562447B1 (de)
JP (3) JP2006507283A (de)
KR (2) KR101186898B1 (de)
AT (2) ATE416629T1 (de)
AU (2) AU2003282829B2 (de)
CA (2) CA2503363C (de)
DE (2) DE60325265D1 (de)
DK (2) DK1562447T3 (de)
ES (1) ES2322577T3 (de)
NZ (1) NZ540165A (de)
PT (2) PT1562447E (de)
TW (2) TWI337066B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE416629T1 (de) * 2002-10-23 2008-12-15 Quercegen Holdings Llc Antioxidative zusammensetzungen
KR101154616B1 (ko) * 2004-12-31 2012-06-08 (주)아모레퍼시픽 캄페롤 및 퀘르세틴을 함유하는 히알루론산 생성 촉진용조성물
JP4601570B2 (ja) * 2006-03-20 2010-12-22 株式会社ロッテ 抗酸化剤及びその製造方法並びに該抗酸化剤を含有する飲食品
EP2040708B1 (de) * 2006-07-17 2018-03-14 Thomas Christian Lines Quercetinhaltige zusammensetzungen
JP5399864B2 (ja) * 2008-11-10 2014-01-29 花王株式会社 精製茶抽出物
CN102802626B (zh) * 2009-06-11 2015-11-25 帝斯曼知识产权资产管理有限公司 作为肌肉刺激剂的烟酸和/或葫芦巴碱
JP5688234B2 (ja) * 2010-03-12 2015-03-25 株式会社ヤマノホールディングス L‐アスコルビン酸含有粉の製造方法
CN103096737A (zh) * 2010-09-17 2013-05-08 斯托克里-丰康普公司 减少血液乳酸盐浓度的方法
JP2012085568A (ja) * 2010-10-18 2012-05-10 Kao Corp ゼリー状食品
US20130129680A1 (en) * 2011-11-23 2013-05-23 Thomas Christian Lines Method for treating hepatitis c virus infection using quercetin-containing compositions
TW201340888A (zh) * 2012-03-09 2013-10-16 Takeda Pharmaceutical 內服用液劑
EP3345606A1 (de) * 2012-11-01 2018-07-11 Rijksuniversiteit Groningen Verfahren und zusammensetzungen zum anregen von nützlichen bakterien im verdauungstrakt
JP6752012B2 (ja) * 2015-11-13 2020-09-09 太陽化学株式会社 テルペノイド減少抑制剤
CN106349149B (zh) * 2016-08-03 2018-12-18 沅江华龙催化科技有限公司 一种由nhpi与酮类化合物直接偶联制备pino衍生物的方法
CN106278991B (zh) * 2016-08-03 2018-10-26 沅江华龙催化科技有限公司 一种由nhpi与含苄基化合物在非金属催化下直接偶联制备pino衍生物的方法
CN106306887A (zh) * 2016-08-19 2017-01-11 朱路 一种可以缓解婴儿吐奶不适性的植物维生素滴剂
CA3121235A1 (en) 2018-11-30 2020-06-04 Beth Israel Deaconess Medical Center, Inc. Compositions and methods for reducing major thrombotic events in cancer patients
CN112021573A (zh) * 2020-05-26 2020-12-04 上海轻姿健康管理有限公司 一种提高耐力的运动营养组合物
BR112023004232A2 (pt) * 2020-10-30 2023-05-09 Nestle Sa Composições contendo nicotinamida e vitamina b6 e métodos de uso de tais composições para tratar sarcopenia e debilidade
KR20230121866A (ko) * 2020-12-18 2023-08-21 산토리 홀딩스 가부시키가이샤 근육의 유연성 개선용 조성물
JPWO2024101207A1 (de) * 2022-11-07 2024-05-16

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3130327B2 (ja) * 1991-03-29 2001-01-31 日鉱金属株式会社 肝機能障害予防剤及び肝機能障害予防作用を有する機能性食品
AT407942B (de) * 1997-04-16 2001-07-25 Husz Georg Bela Getränk, konzentrat-kombination sowie verfahren zur herstellung eines getränkes
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
US7041652B1 (en) * 1998-08-27 2006-05-09 Merck Patent Gmbh Ascorbate-isoquercetin compositions
US6261589B1 (en) * 1999-03-02 2001-07-17 Durk Pearson Dietary supplement nutrient soft drink composition with psychoactive effect
US6210701B1 (en) * 1999-04-30 2001-04-03 Healthcomm International, Inc. Medical food for treating inflammation-related diseases
US6299925B1 (en) * 1999-06-29 2001-10-09 Xel Herbaceuticals, Inc. Effervescent green tea extract formulation
US6579544B1 (en) * 2000-05-31 2003-06-17 Nutriex, L.L.C. Method for supplementing the diet
US6511675B2 (en) * 2000-06-12 2003-01-28 Access Business Group International, Llc Composition and method for correcting a dietary phytochemical deficiency
AU2001277940A1 (en) * 2000-07-20 2002-02-05 Bradford D. Pitman Dietary supplement compositions
JP4043194B2 (ja) * 2001-02-15 2008-02-06 株式会社大貴 不織布及び該不織布の製造方法
WO2003028747A1 (en) * 2001-10-04 2003-04-10 Harris Dennis H Ingestible nerve and circulatory nutritional formulation
ATE416629T1 (de) * 2002-10-23 2008-12-15 Quercegen Holdings Llc Antioxidative zusammensetzungen

Also Published As

Publication number Publication date
AU2003282829B2 (en) 2010-07-22
AU2003284919A1 (en) 2004-05-13
NZ540165A (en) 2008-10-31
EP1562449B1 (de) 2011-03-09
DE60325265D1 (de) 2009-01-22
EP1562449A1 (de) 2005-08-17
AU2003282829A1 (en) 2004-05-13
DE60336336D1 (de) 2011-04-21
ATE500747T1 (de) 2011-03-15
KR101186898B1 (ko) 2012-10-02
EP1562447A1 (de) 2005-08-17
CA2503373C (en) 2013-01-15
EP1562447B1 (de) 2008-12-10
TWI337066B (en) 2011-02-11
KR20050103268A (ko) 2005-10-28
TWI383753B (zh) 2013-02-01
CA2503363A1 (en) 2004-05-06
TW200412863A (en) 2004-08-01
PT1562449E (pt) 2011-06-16
HK1086725A1 (zh) 2006-09-29
JP2006503896A (ja) 2006-02-02
EP1562449A4 (de) 2008-02-20
DK1562447T3 (da) 2009-04-06
CA2503373A1 (en) 2004-05-06
CA2503363C (en) 2012-01-17
TW200409601A (en) 2004-06-16
DK1562449T3 (da) 2011-06-06
JP2006507283A (ja) 2006-03-02
PT1562447E (pt) 2009-03-17
ES2322577T3 (es) 2009-06-23
EP1562447A4 (de) 2006-04-12
KR20050088994A (ko) 2005-09-07
JP2011157366A (ja) 2011-08-18

Similar Documents

Publication Publication Date Title
DK1562447T3 (da) Antioxidative sammensætninger
WO2002081651A3 (en) Polyphenolics for enhancing endothelial cell-mediated fibrinolysis
SG149857A1 (en) Oral care compositions containing free-b-ring flavonoids and flavans
MX2017011884A (es) Composiciones cosmeticas topicas contra radicales libres.
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
ZA200500877B (en) Antimicrobial aza-bicyclic derivatives, their compositions and uses.
ECSP044981A (es) Composicion oftalmica que comprende ascomicina
BRPI0807528A2 (pt) Composições lubrificantes pessoais complementares
AU2003293592A8 (en) Novel nutraceutical compositions comprising epigallocatechin gallate
MX378687B (es) Formulacion de vitamina soluble en grasa.
CL2007002106A1 (es) COMPOSICION MONOFASICA LIQUIDA QUE COMPRENDE 3 ANTIOXIDANTES, 1o, COMPUESTO FENOLICO SINTETICO QUE NO ES DERIVADO DE QUINOOLINA, 2o, ACIDOS FENOLICO, ASCORBICO, TOCOFEROLES, LECITINA, BIOFLAVONOIDE O TERPENOIDE Y 3o, COMPUESTO DERIVADO DE QUINOLINA;
IT1320080B1 (it) Composizione per uso farmaceutico o dietetico.
BRPI0607651A2 (pt) composições contendo lignano
FR2842103B1 (fr) Nouvelles applications cosmetiques de polyphenoles et de leurs derives
TW200700071A (en) Novel use
WO2007013901A3 (en) Color-stabilization of aromachemicals
DK1965809T3 (da) Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner
PL1843778T3 (pl) Kompozycje zawierające galusan epigalokatechiny i hydrolizat białkowy
WO2007075255A3 (en) Mastic gum composition for use as a dietary supplement in humans and animals
WO2008070354A3 (en) 5- and 6- substituted benzimidazole thiophene compounds
EP1773354A4 (de) Vitamin b12 zusammensetzungen
DK1360011T3 (da) Rotor til slagle- eller hakkemölle
NO20080722L (no) Anvendelse av 4-(3,4-dijklorfenyl)-1,2,3,4-tetrahydronaftalen-1-ylamin for behandling av kreft
IL180777A (en) Chromen-2- one derivatives, pharmaceutical compositions comprising them and uses thereof
TW200637596A (en) Oral care compositions containing flavonoids and flavans

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1562447

Country of ref document: EP